BEVERLY HILLS, Calif.,
March 4, 2014 /PRNewswire/ --
Cannabis Capital Corp. (CBCA) fka World Stevia Corp (WSTV) is a
Company focused on high-growth acquisitions within the Cannabis
Industry.
Effective today, FINRA has approved Cannabis Capital's name
change and symbol for trading. The Company is fully reporting
and audited, with its shares listed for trading on the OTC with
symbol "CBCA" under the leadership of its President & CEO
Chad S. Johnson, Esq., and its CFO
Robert Kane, backed by an extended
team of seasoned investors, associates, and advisors.
This large International emerging market within the cannabis
industry has born countless successful business models, and
attractive opportunities have developed on a worldwide basis.
Within the United States alone,
there are over 20 states participating or investing in diverse
business activities in the expanding cannabis industry in one
manner or another, one that has widely been deemed a breakthrough
market for savvy investors. The Cannabis Capital management
team has the understanding, expertise, and sophistication required
to create the effective strategies for establishing Cannabis
Capital as a key player in the market.
"New and emerging markets in the cannabis industry are
considered highly valuable; as the industry grows and matures, so
will the range, depth and diversity of businesses within
it. We have already identified a few key acquisition
opportunities to start the process of accelerating our growth
plans. We at Cannabis Capital look forward to solidifying a
premiere role in the development of the cannabis industry around
the world -- in multiple capacities that support and surpass the
seed to sale model," said Chad S. Johnson,
Esq., President & CEO, Cannabis Capital Corp.
Chad S.
Johnson - President, Chief Executive
Officer & Director
Mr. Johnson, a graduate of Harvard
College and Harvard Law School,
followed a federal judicial clerkship with a position as an
attorney for the renown law firm of Skadden Arps Slate Meagher
& Flom LLP, where Mr. Johnson focused on representation of
banking and financial institutions in the context of mergers,
acquisitions, and regulatory advice. During his seven years
at Skadden, Mr. Johnson also served as founder, pro bono general
counsel, and/or director for several civil rights, AIDS, religious,
and progressive political organizations, receiving the second pro
bono award from the firm to serve as a Skadden Legal Aid Society
attorney. Mr. Johnson left the firm in 2000 to work full-time
with the Gore/Lieberman campaign and subsequent recount
effort. He then served as executive director of the national
LGBT Democrats' organization for two years before pursuing various
entrepreneurial ventures, while also serving as chief of staff and
general counsel for a premier cosmetic surgery center from
September 2003 to February 2013, gaining key insight into law and
medicine through interaction with patients, physicians, and
industry partners. Mr. Johnson co-founded the non-profit World AIDS
Institute and Timothy Ray Brown Foundation. He has founded or
served on the boards of directors for several political action
committees (PACs) and issue-advocacy or lobbying organizations in
Washington, DC. Currently, Mr.
Johnson holds executive positions on the boards of multiple
corporations and non-profit organizations, including Cannabis
Science, Inc., Endocan Corporation, and the Future of Nicaragua
Foundation.
Robert
Kane - Chief Financial Officer &
Director
Mr. Kane wrote his first business plan in 1996.
In 1998, he was hired at Ryan, Beck, and Company,
subsequently acquired by the 120-year-old financial firm, Stifel
Nicolaus, as a successful registered representative. In 2009
Mr. Kane walked away from the financial markets to start his own
firm to specialize in business and management planning, investor
presentations, and investor relations for the cannabis
industry. Mr. Kane also held the position of Director of
Investor Relations for Medical Marijuana, Inc., the first publicly
traded medical marijuana company. Mr. Kane also held the position
of Chief Financial Officer for Cannabiz Business University when
they hosted the Medical Cannabis Educational Symposium in Hawai'i
in 2011. Among many industry accomplishments, Mr. Kane
blueprinted one of the industry's early private equity funds and
has worked on state legislation in multiple states to provide
economic interpretations and projections for the cannabis
industry. In 2012, Mr. Kane sold his firm to Cannabis
Science, Inc. (CBIS) and consulted in investor relations until his
promotion to CFO in 2013. Mr. Kane also sits as a
director and CFO for Endocan Corporation, a strategic partner of
Cannabis Science.
Forward Looking Statements
This Press Release includes forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Act of 1934. A statement containing
works such as "anticipate," "seek," intend," "believe," "estimate,"
"expect," "project," "plan," or similar phrases may be deemed
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. Some or all of the events
or results anticipated by these forward-looking statements may not
occur. Factors that could cause or contribute to such differences
include the future U.S. and global economies, the impact of
competition, and the Company's reliance on existing regulations
regarding the use and development of cannabis-based drugs. Cannabis
Capital Corp. does not undertake any duty nor does it intend to
update the results of these forward-looking statements.
Cannabis Capital Corp.
Chad S. Johnson, President, CEO
& Director
chad.johnson@cannabiscapitalcorp.com
202.253.1382
Investment Inquiries
Robert Kane, CFO & Director
robert.kane@cannabiscapitalcorp.com
561.420.4824
SOURCE Cannabis Capital Corp.